Compare AUPH & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUPH | BKV |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2014 | 2022 |
| Metric | AUPH | BKV |
|---|---|---|
| Price | $14.88 | $17.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $18.50 | ★ $31.36 |
| AVG Volume (30 Days) | 819.4K | ★ 1.5M |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 199.00 |
| EPS | 0.76 | ★ 1.37 |
| Revenue | $283,055,000.00 | ★ $893,781,000.00 |
| Revenue This Year | $16.65 | $49.27 |
| Revenue Next Year | $17.73 | N/A |
| P/E Ratio | $19.89 | ★ $13.64 |
| Revenue Growth | N/A | ★ 47.85 |
| 52 Week Low | $13.52 | $17.53 |
| 52 Week High | $19.25 | $32.81 |
| Indicator | AUPH | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 32.08 |
| Support Level | $14.76 | $17.53 |
| Resistance Level | $15.15 | $27.40 |
| Average True Range (ATR) | 0.53 | 0.86 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 4.44 | 13.54 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.